- Home
- RAND vs CCEL Comparison
RAND vs CCEL Comparison
Compare RAND & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAND
- CCEL
- Stock Information
- Founded
- RAND 1969
- CCEL 1989
- Country
- RAND United States
- CCEL United States
- Employees
- RAND N/A
- CCEL N/A
- Industry
- RAND Finance: Consumer Services
- CCEL Managed Health Care
- Sector
- RAND Finance
- CCEL Health Care
- Exchange
- RAND Nasdaq
- CCEL Nasdaq
- Market Cap
- RAND 57.6M
- CCEL 39.9M
- IPO Year
- RAND N/A
- CCEL 1997
- Fundamental
- Price
- RAND $17.43
- CCEL $4.83
- Analyst Decision
- RAND
- CCEL Strong Buy
- Analyst Count
- RAND 0
- CCEL 1
- Target Price
- RAND N/A
- CCEL $8.50
- AVG Volume (30 Days)
- RAND 4.9K
- CCEL 13.2K
- Earning Date
- RAND 08-05-2025
- CCEL 07-22-2025
- Dividend Yield
- RAND 10.01%
- CCEL 20.62%
- EPS Growth
- RAND 39.77
- CCEL N/A
- EPS
- RAND 3.12
- CCEL 0.01
- Revenue
- RAND $8,499,970.00
- CCEL $32,102,750.00
- Revenue This Year
- RAND N/A
- CCEL $2.49
- Revenue Next Year
- RAND N/A
- CCEL $0.95
- P/E Ratio
- RAND $5.60
- CCEL $301.41
- Revenue Growth
- RAND 12.52
- CCEL 2.33
- 52 Week Low
- RAND $14.93
- CCEL $4.75
- 52 Week High
- RAND $31.89
- CCEL $9.43
- Technical
- Relative Strength Index (RSI)
- RAND 69.52
- CCEL 40.85
- Support Level
- RAND $16.26
- CCEL $4.80
- Resistance Level
- RAND $16.89
- CCEL $6.35
- Average True Range (ATR)
- RAND 0.49
- CCEL 0.26
- MACD
- RAND 0.24
- CCEL -0.03
- Stochastic Oscillator
- RAND 100.00
- CCEL 2.08
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.